Welcome to the international HTA database

Showing [23383 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Evaluations of child and adolescent psychiatry. (Part 1) - Theory and practice about measurement dimensions, indicators and instruments
2009	Belgian Health Care Knowledge Centre (KCE)	Use of point-of-care devices in patients with oral anticoagulation : a Health Technology Assessment
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009	Belgian Health Care Knowledge Centre (KCE)	Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: rapid assessment
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Telemedicine in Stroke Management. Systematic Review
2009	HAYES, Inc.	Chromoendoscopy for colonoscopy
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography for pediatric patients: review of clinical effectiveness and indications for use
2009	University of York	Cognitive behaviour therapy for schizophrenia
2009	Belgian Health Care Knowledge Centre (KCE)	Robot-assisted surgery: health technology assessment
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Systematic review of the multidisciplinary combined treatment in peritoneal neoplasms. Radical surgical citoreduction + intraperitoneal chemotherapy +/- hyperthermia (Sugarbaker's technique)
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Tocolysis in preterm labour - a systematic review of evidence-based guidelines, effectiveness and health economic evaluations
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009	University of York	Physical health monitoring for people with schizophrenia or other serious mental illness
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Hybrid revascularization
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low molecular weight heparins: review of the comparative effectiveness for various indications
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Reprocessing of surgical drills
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Technologies for the identification of osteoporosis
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for surgical pain management
2009	HAYES, Inc.	Combining multislice computed tomography imaging with electroanatomic mapping to guide radiofrequency catheter ablation procedures for atrial fibrillation
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Specialty mattresses for the prevention and management of pressure ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Prostheses for primary total knee replacement in Italy
2009	Belgian Health Care Knowledge Centre (KCE)	Use of point-of care devices in patients with oral anticoagulation: a health technology assessment
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Venous thromboembolism prophylaxis for bariatric surgery
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Artificial food colours and hyperactivity
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention of surgical site infections
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009	Agency for Health Technology Assessment in Poland (AHTAPol)	Clinical effectiveness analysis of bosentan, epoprostenol, iloprost, sildenafil and treprostinil in treatment of pulmonary arterial hypertension: a systematic review of randomised controlled trials
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009	HAYES, Inc.	Computerized provider order entry for medications: adult inpatients
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Descemet stripping automated endothelial keratoplasty: a review of the clinical and cost-effectiveness
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Clinical practice guideline on eating disorders
2009	HAYES, Inc.	Craniosacral therapy
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Nonmedical secondary prevention of patients with coronary heart disease]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hyperbaric oxygen therapy for autism: a review of the clinical and cost-effectiveness
2009	VA Technology Assessment Program (VATAP)	Health risks from cellular phone use
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Arthroplasty register for Germany]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Casting for foot orthotics: a review of the clinical and cost-effectiveness
2009	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Smoking cessation among patients in general practice - a health technology assessment]
2009	HAYES, Inc.	3.0 Tesla (3T) Magnetic Resonance Imaging (MRI) for Prostate Cancer
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for mood disorders: a review of the clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Topotecan for the treatment of relapsed small-cell lung cancer. NICE technology appraisal guidance 184
2009	HAYES, Inc.	Echinacea for prevention or treatment of the common cold
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Age-related macular degeneration: the role of current treatment strategies]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for adults with axis II disorders: a review of clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Topotecan for the treatment of recurrent and stage IVB cervical cancer. NICE technology appraisal guidance 183
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Allen test for predicting complications from arterial cannulation
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for podiatry
2009	Institute for Clinical Evaluative Sciences (ICES)	Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for anxiety: a review of the clinical effectiveness
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2009	Agency for Healthcare Research and Quality (AHRQ)	Use of Bayesian techniques in randomized clinical trials: a CMS case study
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2009	Penn Medicine Center for Evidence-based Practice (CEP)	IV injection sites for post-mastectomy patients
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Amotosalen (Intercept) for the inactivation of pathogens for transfusion therapy]
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for amyotrophic lateral sclerosis
2009	Institute for Clinical Evaluative Sciences (ICES)	What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy in the treatment of schizophrenia: a review of the clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the treatment of gastrointestinal stromal tumours. NICE technology appraisal guidance 179
2009	Medical Advisory Secretariat (MAS)	Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009	Penn Medicine Center for Evidence-based Practice (CEP)	IV placement in chronic kidney disease patients
2009	Blue Cross Blue Shield Association (BCBS)	CT colonography (virtual colonoscopy) for colon cancer screening
2009	The Swedish Council on Health Technology Assessment (SBU)	[How can drug consumption among the elderly be improved?]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Angiographic profile of patients undergoing drug eluting stent implantation in Spain. Variability of off-label indications]
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for nurse-led primary care
2009	Institute for Clinical Evaluative Sciences (ICES)	Registry of the Canadian Stroke Network. Report on the 2004/05 Ontario Stroke Audit
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pathogen reduction technologies for blood products: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009	National Institute for Health and Care Excellence (NICE)	Pemetrexed for the first-line treatment of non-small-cell lung cancer. NICE technology appraisal guidance 181
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Medical and health economic assessment of radiosurgery for the treatment of brain metastasis]
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention of ventilator-associated pneumonia
2009	Blue Cross Blue Shield Association (BCBS)	Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Artificial liver support systems]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009	National Institute for Health and Care Excellence (NICE)	Alitretinoin for the treatment of severe chronic hand eczema. NICE technology appraisal guidance 177
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention and management of delirium
2009	HAYES, Inc.	Endoscopic retrograde cholangiopancreatography for the treatment of benign and malignant diseases of the pancreas and biliary tree
2009	Blue Cross Blue Shield Association (BCBS)	Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009	VA Technology Assessment Program (VATAP)	Regionalization of surgical services
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 178
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Reuse of single use medical devices]
2009	Agency for Healthcare Research and Quality (AHRQ)	Horizon Scan: to what extent do changes in third-party payment affect clinical trials and the evidence base
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Prostacyclins (epoprostenol, iloprost, treprostinil and beraprost) for the management of primary pulmonary hypertension and pulmonary hypertension in collagen vascular disease
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to great saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2009	HAYES, Inc.	Nanoparticle-based cancer therapies: Albumin-bound paclitaxel
2009	VA Technology Assessment Program (VATAP)	Simulation training
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Tenofovir disoproxil for the treatment of chronic hepatitis B. NICE technology appraisal guidance 173
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Effects and costs of a combined screening and treatment program for elderly (aged 75 years and over) with depressive symptoms in general practice]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Behavioural and skill-based early interventions in children with autism spectrum disorders]
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to small saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Defibrillators in public places]